Neurological Biomarkers Market Worth $14.45 Billion by 2027 – Comprehensive Report by The Insight Partners
October 30, 2023 07:32 ET
|
The Insight Partners
Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Biomarkers are the molecules that indicate the presence of a disease. The biomarkers of the neurological disorders were not that accessible in earlier...
Biomarkers Market to Hit US$ 215.7 Billion at a CAGR of 14.3% by 2033 : Marketresearch.biz Report
October 30, 2023 05:38 ET
|
MarketResearch.biz
New York, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The biomarkers market, valued at USD 58.6 billion in 2022, is projected to witness a CAGR of 14.3% from 2023 to 2032. It is expected to reach USD 215.7...
Alzheimer’s Disease Biomarkers Market Predicted to Reach USD 1.7 billion by 2031, Expanding at a 7.5% CAGR Says, Transparency Market Research Inc.
August 14, 2023 07:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global Alzheimer’s disease biomarkers market is expected to be valued at US$ 953.54...
Global Thrombosis and Hemostasis Biomarkers Market Size
June 14, 2023 08:32 ET
|
Global Market Estimates
Brooklyn, New York, June 14, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Thrombosis and Hemostasis Biomarkers Market is...
Specimen Validity Testing Market to surpass USD 4.7 billion by 2032, Says Graphical Research Powered by GMI
June 13, 2023 17:00 ET
|
Graphical Research
Selbyville, Delaware, June 13, 2023 (GLOBE NEWSWIRE) -- Specimen Validity Testing Market size is set to record more than USD 4.7 billion by 2032. The development and innovation of advanced testing...
Genomics Services Market to surpass USD 12.3 billion by 2032, Says Graphical Research Powered by GMI
June 12, 2023 19:30 ET
|
Graphical Research
Selbyville, Delaware, June 12, 2023 (GLOBE NEWSWIRE) -- Genomics Services Market size is expected to exceed USD 12.3 billion by 2032. The genomic services industry has experienced significant...
NuProbe BDA Technology Enables Highly Sensitive Detection of Low-Level Variants for Oncology Research
May 03, 2023 10:00 ET
|
NuProbe USA Inc
Houston, May 03, 2023 (GLOBE NEWSWIRE) -- NuProbe, a genomics company developing ultrasensitive research assays for detecting and monitoring low-frequency mutations, gene fusions, and copy number...
USD 12.6 Bn Cancer Biomarkers Market to Grow at a CAGR of 9.9% During 2022 to 2031 - Global Analysis by Transparency Market Research
April 26, 2023 06:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, April 26, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research, tThe global cancer biomarkers market size stood at USD 12.6 Bn in 2021. The market...
RetinAI Joins Forces with Boehringer Ingelheim to Advance Novel Treatments for Patients with Geographic Atrophy using Artificial Intelligence
April 21, 2023 03:00 ET
|
RetinAI Medical AG
BERN, Switzerland and BOSTON, April 21, 2023 (GLOBE NEWSWIRE) -- RetinAI Medical AG (“RetinAI”), a leader in clinical and imaging data management software and advanced analytics using artificial...
Congestive Heart Failure Drugs Market Size to Cross USD 13.5 Bn Revenue by 2031 | TMR Study
April 13, 2023 17:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, April 14, 2023 (GLOBE NEWSWIRE) -- The global congestive heart failure drugs market was valued at USD 6.7 Bn in 2022 and is estimated to reach USD 13.5 Bn by...